TopFunds

Merck & Co., Inc.

NYSE: MRK

Stock price

127.5 USD

(+Infinity%) NaN day

Drug Manufacturers - General

Financial Performance

Share

5Y price score: 87

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: 167.8%

DATE RANGE:

US$ Per
Share

    Time scale:

    By default your notes are visible only to you.

    76.6

    52-week range

    131.7

    127.5

    Your model inputs

    Required return / cost of capital
    %
    FCFF terminal growth rate
    %

    Your fair value & Margin of safety

    To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

    Forecast:

    Valuation

    Free Cash Flow Yield

    Help
    FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

    4.4 %

    Dividend Yield TTM

    2.6 %

    Market cap $

    $ 314,903

    Price / Earnings TTM

    Help
    P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

    35.9

    Price / Book TTM

    6.9

    PEG TTM

    Help
    Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

    4.5

    Earnings growth and return

    LTM

    5YR

    10YR

    Total return (price & dividends)

    60.4 %

    82.4 %

    167.8 %

    Free cash flow per share growth

    (30.8) %

    115.1 %

    25.8 %

    Earnings per share growth

    8 %

    161.9 %

    366.7 %

    Founded: 1,891

    Employees: 73,000

    Business Summary:Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

    Fair Value Reference Estimate

    Latest Earnings Call Takeaways

    Annual Reports, Presentations And IR Contacts

    Go to the website
    Annual report links (10K)
    2025202420232022202120202019201820172016

    Merck & Co., Inc. — Financial Overview, Stock Price, Market Cap

    Merck & Co., Inc. is a company. Founded in 1891. As of July 20, 2026, the company's market capitalization is $314902612913 with a current stock price of $127.50.